The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R
Abstract
IL-23 is a heterodimeric cytokine composed of the IL-12p40 “soluble receptor” subunit and a novel cytokine-like subunit related to IL-12p35, termed p19. Human and mouse IL-23 exhibit some activities similar to IL-12, but differ in their capacities to stimulate particular populations of memory T cells. Like IL-12, IL-23 binds to the IL-12R subunit IL-12Rβ1. However, it does not use IL-12Rβ2. In this study, we identify a novel member of the hemopoietin receptor family as a subunit of the receptor for IL-23, “IL-23R.” IL-23R pairs with IL-12Rβ1 to confer IL-23 responsiveness on cells expressing both subunits. Human IL-23, but not IL-12, exhibits detectable affinity for human IL-23R. Anti-IL-12Rβ1 and anti-IL-23R Abs block IL-23 responses of an NK cell line and Ba/F3 cells expressing the two receptor chains. IL-23 activates the same Jak-stat signaling molecules as IL-12: Jak2, Tyk2, and stat1, -3, -4, and -5, but stat4 activation is substantially weaker and different DNA-binding stat complexes form in response to IL-23 compared with IL-12. IL-23R associates constitutively with Jak2 and in a ligand-dependent manner with stat3. The ability of cells to respond to IL-23 or IL-12 correlates with expression of IL-23R or IL-12Rβ2, respectively. The human IL-23R gene is on human chromosome 1 within 150 kb of IL-12Rβ2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Self-citationInterleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Structural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069
Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice
Kaplan, M. H., Sun, Y.-L., Hoey, T., & Grusby, M. J. (1996) · Nature · doi:10.1038/382174a0 · Cited by 1,240
Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells
Thierfelder, W. E., van Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. R., Carson, R. T., Sangster, M. Y., Vignali, D. A. A., Doherty, P. C., Grosveld, G. C., et al. (1996) · Nature · doi:10.1038/382171a0 · Cited by 1,180
Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B., Menon, S., Kastelein, R., Bazan, F., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80378-7 · Cited by 720
Self-citationJacobson, N. G., Szabo, S. J., Weber-Nordt, R. M., Zhong, Z., Schreiber, R. D., Darnell, J. E., & Murphy, K. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1755 · Cited by 673
A simple, non-chromatographic procedure to purify immunoglobulins from serum and ascites fluid
McKinney, M. M., & Parkinson, A. (1987) · Journal of Immunological Methods · doi:10.1016/0022-1759(87)90324-3 · Cited by 616
A bioactive designer cytokine for human hematopoietic progenitor cell expansion
Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J. P. G., Kallen, K.-J., Wollmer, A., Grötzinger, J., & Rose-John, S. (1997) · Nature Biotechnology · doi:10.1038/nbt0297-142 · Cited by 530
Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes.
Bacon, C. M., Petricoin, E. F., Ortaldo, J. R., Rees, R. C., Larner, A. C., Johnston, J. A., & O'Shea, J. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7307 · Cited by 449
Cited by
Items 101–139 of 139
Cho, M.-L., Kang, J.-W., Moon, Y.-M., Nam, H.-J., Jhun, J.-Y., Heo, S.-B., Jin, H.-T., Min, S.-Y., Ju, J.-H., Park, K.-S., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5652 · Cited by 313
Low Penetrance, Broad Resistance, and Favorable Outcome of Interleukin 12 Receptor β1 Deficiency
Fieschi, C., Dupuis, S., Catherinot, E., Feinberg, J., Bustamante, J., Breiman, A., Altare, F., Baretto, R., Le Deist, F., Kayal, S., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021769 · Cited by 312
New insights into the pathogenesis of Behçet's disease
Pineton de Chambrun, M., Wechsler, B., Geri, G., Cacoub, P., & Saadoun, D. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.026 · Cited by 309
Zhang, G.-X., Gran, B., Yu, S., Li, J., Siglienti, I., Chen, X., Kamoun, M., & Rostami, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2153 · Cited by 305
A new modality for immunosuppression: targeting the JAK/STAT pathway
O'Shea, J. J., Pesu, M., Borie, D. C., & Changelian, P. S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1441 · Cited by 303
Th17 cells: a new fate for differentiating helper T cells
Chen, Z., & O’Shea, J. J. (2008) · Immunologic Research · doi:10.1007/s12026-007-8014-9 · Cited by 300
Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn Disease
Wang, K., Zhang, H., Kugathasan, S., Annese, V., Bradfield, J. P., Russell, R. K., Sleiman, P. M. A., Imielinski, M., Glessner, J., Hou, C., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.01.026 · Cited by 291
Interleukin-23/Th17 pathways and inflammatory bowel disease
Abraham, C., & Cho, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20894 · Cited by 289
Effector and Regulatory T-cell Subsets in Autoimmunity and Tissue Inflammation
Jäger, A., & Kuchroo, V. K. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02432.x · Cited by 282
Interleukin-23: A key cytokine in inflammatory diseases
Duvallet, E., Semerano, L., Assier, E., Falgarone, G., & Boissier, M.-C. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.577093 · Cited by 282
T-bet is essential for encephalitogenicity of both Th1 and Th17 cells
Yang, Y., Weiner, J., Liu, Y., Smith, A. J., Huss, D. J., Winger, R., Peng, H., Cravens, P. D., Racke, M. K., & Lovett-Racke, A. E. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082584 · Cited by 282
Schmidt, C., Giese, T., Ludwig, B., Mueller-Molaian, I., Marth, T., Zeuzem, S., Meuer, S. C., & Stallmach, A. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200501000-00003 · Cited by 280
The role of cytokines in the regulation of NK cells in the tumor environment
Konjević, G. M., Vuletić, A. M., Mirjačić Martinović, K. M., Larsen, A. K., & Jurišić, V. B. (2019) · Cytokine · doi:10.1016/j.cyto.2019.02.001 · Cited by 279
Muñoz, M., Heimesaat, M. M., Danker, K., Struck, D., Lohmann, U., Plickert, R., Bereswill, S., Fischer, A., Dunay, I. R., Wolk, K., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090900 · Cited by 277
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination
Rostami, A., & Ciric, B. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.03.002 · Cited by 275
On safari to Random Jungle: a fast implementation of Random Forests for high-dimensional data
Schwarz, D. F., König, I. R., & Ziegler, A. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq257 · Cited by 269
Novel IL-12 family members shed light on the orchestration of Th1 responses
Brombacher, F. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00067-x · Cited by 269
The role of cytokines in inflammatory bone loss
Souza, P. P. C., & Lerner, U. H. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.822766 · Cited by 269
Microbiome, inflammation and colorectal cancer
Chen, J., Pitmon, E., & Wang, K. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.006 · Cited by 265
Hamano, S., Himeno, K., Miyazaki, Y., Ishii, K., Yamanaka, A., Takeda, A., Zhang, M., Hisaeda, H., Mak, T. W., Yoshimura, A., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00298-x · Cited by 264
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment
Habanjar, O., Bingula, R., Decombat, C., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044002 · Cited by 263
β‐glucan triggers spondylarthritis and Crohn's disease–like ileitis in SKG mice
Ruutu, M., Thomas, G., Steck, R., Degli‐Esposti, M. A., Zinkernagel, M. S., Alexander, K., Velasco, J., Strutton, G., Tran, A., Benham, H., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34423 · Cited by 262
Di Meglio, P., Di Cesare, A., Laggner, U., Chu, C.-C., Napolitano, L., Villanova, F., Tosi, I., Capon, F., Trembath, R. C., Peris, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017160 · Cited by 262
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
Verstockt, B., Salas, A., Sands, B. E., Abraham, C., Leibovitzh, H., Neurath, M. F., Vande Casteele, N., Alimentiv Translational Research Consortium (ATRC), Danese, S., D’Haens, G., et al. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00768-1 · Cited by 261
Interleukin‐35: odd one out or part of the family?
Collison, L. W., & Vignali, D. A. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00704.x · Cited by 260
Th17 cells: from precursors to players in inflammation and infection
Awasthi, A., & Kuchroo, V. K. (2009) · International Immunology · doi:10.1093/intimm/dxp021 · Cited by 241
Fairweather, D., Yusung, S., Frisancho, S., Barrett, M., Gatewood, S., Steele, R., & Rose, N. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4731 · Cited by 229
“and stimulates IFN- production from memory T cells (32), was”
BackgroundFrom interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited
Boniface, K., Blom, B., Liu, Y., & De Waal Malefyt, R. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00714.x · Cited by 218
“These results are in agreement with the observation that CD45RB cells expressed high levels of IL-12Rb2 and lacked IL-23R, whereas CD45RB cells expressed IL-23R but low levels of IL-12Rb2, and thus indicate that IL-23 preferentially acts as a growth factor for memory T cells (21).”
BackgroundResultYang, C.-Y., Ma, X., Tsuneyama, K., Huang, S., Takahashi, T., Chalasani, N. P., Bowlus, C. L., Yang, G.-X., Leung, P. S. C., Ansari, A. A., et al. (2014) · Hepatology · doi:10.1002/hep.26979 · Cited by 213
“IL-12 signals through a heterodimeric receptor composed of the IL-12RB2/IL-12RB1 chains9 and stimulates the growth and function of T cells and natural killer cells, which in turn produce interferon (IFN)-c and tumor necrosis factor (TNF)-a.10 The cytokine IL-23 on the other hand consists of two subunits, p19 and the s…”
BackgroundEtiology and Pathogenesis of Psoriasis
Boehncke, W.-H. (2015) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.07.013 · Cited by 197
Glassman, C. R., Mathiharan, Y. K., Jude, K. M., Su, L., Panova, O., Lupardus, P. J., Spangler, J. B., Ely, L. K., Thomas, C., Skiniotis, G., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.018 · Cited by 181
Hou, Y., Zhu, L., Tian, H., Sun, H.-X., Wang, R., Zhang, L., & Zhao, Y. (2018) · Protein & Cell · doi:10.1007/s13238-018-0505-z · Cited by 179
Musolino, C., Allegra, A., Innao, V., Allegra, A. G., Pioggia, G., & Gangemi, S. (2017) · Mediators of Inflammation · doi:10.1155/2017/1852517 · Cited by 168
Interleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells
Jain, R., Chen, Y., Kanno, Y., Joyce-Shaikh, B., Vahedi, G., Hirahara, K., Blumenschein, W. M., Sukumar, S., Haines, C. J., Sadekova, S., et al. (2016) · Immunity · doi:10.1016/j.immuni.2015.11.009 · Cited by 167
Self-citationVanden Eijnden, S., Goriely, S., De Wit, D., Willems, F., & Goldman, M. (2005) · European Journal of Immunology · doi:10.1002/eji.200425677 · Cited by 148
Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Steele, R. A., Gatewood, S. J. L., & Rose, N. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.261 · Cited by 133
Merson, T. D., Binder, M. D., & Kilpatrick, T. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8112-z · Cited by 84
Identity crisis of Th17 cells: many forms, many functions, many questions
Sundrud, M. S., & Trivigno, C. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.021 · Cited by 77
Shen, H., Wang, Y., Chen, C. Y., Frencher, J., Huang, D., Yang, E., Ryan‐Payseur, B., & Chen, Z. W. (2015) · European Journal of Immunology · doi:10.1002/eji.201444635 · Cited by 39
Metadata
- Authors
- Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., To, W., Wagner, J., O’Farrell, A.-M., McClanahan, T., Zurawski, S., Hannum, C., Gorman, D., Rennick, D. M., Kastelein, R. A., de Waal Malefyt, R., & Moore, K. W.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-06-01
- Volume
- 168
- Issue
- 11
- Pages
- 5699-5708
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1847326477
- Cited by
- 1,296
- References
- 39
- FWCI
- 18.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.